On our Novo Nordisk episode, we covered the business of Ozempic, the GLP-1 taking the world by storm. On this episode, we dive into the science of the molecule semaglutide (and its predecessor liraglutide) with the world expert on the topic, Lotte Bjerre Knudsen. Lotte is Novo Nordisk’s Chief Scientific Advisor, and led the research group back in the early 1990s that first invented the molecule. A few topics from our conversation:
Sponsors:
Reinsurance, Climate + Kindergarten Ventures (with Nat Manning)
The 2022 State of Crypto + Web3 with Solana's Austin Federa
Dissecting ProfitWell's Acquisition (with Patrick Campbell)
David Interviewed on "Unlimited Partners"
Travel for the Creator Economy
Reverse Interview: Ben and David at Vanta
Composer (with CEO Benjamin Rollert)
TradFi vs. Crypto, Explaining BNPL, and What's Next in Fintech (with Bain Capital Ventures' Christina Melas-Kyriazi)
Ben and David on "Capital Allocators"
10-K Diver: Building a Top Fintwit Account and Teaching Finance Principles to Everyone (Pseudonymously!)
NZS Capital Part II: What’s Going on in Today’s Markets? (Plus more Semiconductors!)
Race Capital, Crypto Investing, and FTX + Solana’s Early Days
Italic & a New Era of Online Retail
2021 Recap: Acquired x Not Boring x The Generalist
Mission-Driven Founders, Global Investing, and Canva (with Wesley Chan)
Blue Origin and the 2021 Space Landscape (with Rob Meyerson)
Ben and David on "This Week in Startups" Holiday Special
Joseph Gordon-Levitt: A Fireside Chat
Update on Dad Life, MacBook Pros, and Acquired Video
Web3 Marketplaces (with Braintrust CEO Adam Jackson)
Create your
podcast in
minutes
It is Free
The Commercial Edge: Unleash the Power of People
The emPOWERed Half Hour
Organic Marketing Simplified: Master podcast marketing, fuel podcast growth, and make money podcasting!
THE GO BIZ GUY
The Sigma Femme Podcast
The Prof G Pod with Scott Galloway
The Tim Ferriss Show